RISK OF DEATH IN HOSPITALIZED DOGS WITH HEMOSTATIC PROFILE DISORDERS

Identifying patients who have a higher risk of death is crucial to define appropriate risk classification, treatment and prognosis, which can result in a favorable outcome. The objective of this retrospective study was to evaluate whether the prolongation of prothrombin times, activated partial thromboplastin, and thrombocytopenia are indicators of death risk in hospitalized canine patients. A retrospective study using medical records (2014-2018) of the Laboratory of Veterinary Clinical Analysis at the Federal University of Rio Grande do Sul identified 218 patients. Dogs having a single disorder in laboratory tests did not differ from the control. Groups presenting patients with multiple changes showed three times more death risk than the control group and a cumulative incidence of death higher than 29%.